{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T21:43:44Z","timestamp":1777067024365,"version":"3.51.4"},"reference-count":105,"publisher":"Impact Journals, LLC","issue":"35","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,8,30]]},"DOI":"10.18632\/oncotarget.10598","type":"journal-article","created":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T06:20:13Z","timestamp":1468477213000},"page":"57414-57429","source":"Crossref","is-referenced-by-count":26,"title":["NETs: organ-related epigenetic derangements and potential clinical applications"],"prefix":"10.18632","volume":"7","author":[{"given":"Mauro","family":"Cives","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari \u201cAldo Moro\u201d, Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Simone","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari \u201cAldo Moro\u201d, Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca Maria","family":"Rizzo","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari \u201cAldo Moro\u201d, Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Silvestris","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari \u201cAldo Moro\u201d, Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,7,13]]},"reference":[{"key":"1","first-page":"749","article-title":"An update on gastroenteropancreatic neuroendocrine tumors","volume":"28","author":"Strosberg","year":"2014","journal-title":"Oncology (Williston Park)"},{"key":"2","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1038\/ncomms4518","article-title":"Frequent mutations in chromatin- remodelling genes in pulmonary carcinoids","volume":"5","author":"Bosco","year":"2014","journal-title":"Nat Commun"},{"key":"3","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1126\/science.1200609","article-title":"DAXX\/ATRX MEN1 and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors","volume":"331","author":"Papadopoulos","year":"2011","journal-title":"Science"},{"key":"4","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1038\/ng.2821","article-title":"Somatic mutation of CDKN1B in small intestine neuroendocrine tumors","volume":"45","author":"Philips","year":"2013","journal-title":"Nat Genet"},{"key":"5","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1158\/1078-0432.CCR-15-0373","article-title":"Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor","volume":"22","author":"Novelli","year":"2016","journal-title":"Clin Cancer Res"},{"key":"6","doi-asserted-by":"publisher","first-page":"R65","DOI":"10.1530\/ERC-12-0338","article-title":"Neuroendocrine tumours: cracking the epigenetic code","volume":"20","author":"Thirlwell","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"7","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nrm4043","article-title":"DNA methylation pathways and their crosstalk with histone methylation","volume":"16","author":"Patel","year":"2015","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nrc3932","article-title":"MicroRNA biogenesis pathways in cancer","volume":"15","author":"Gregory","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"9","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.ejca.2009.01.003","article-title":"The promises and pitfalls of epigenetic therapies in solid tumours","volume":"45","author":"Brown","year":"2009","journal-title":"Eur J Cancer"},{"key":"10","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1038\/modpathol.2010.166","article-title":"The origin of neuroendocrine tumors and the neural crest saga","volume":"24 Suppl 2","author":"Rosai","year":"2011","journal-title":"Mod Pathol"},{"key":"11","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.cell.2013.04.022","article-title":"Epigenomic analysis of multilineage differentiation of human embryonic stem cells","volume":"153","author":"Lee","year":"2013","journal-title":"Cell"},{"key":"12","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.tig.2014.04.004","article-title":"Mechanisms of epigenetic memory","volume":"30","author":"Brickner","year":"2014","journal-title":"Trends Genet"},{"key":"13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mce.2013.08.002","article-title":"Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)","volume":"386","author":"Thakker","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"14","doi-asserted-by":"publisher","first-page":"e583","DOI":"10.1038\/cddis.2013.98","article-title":"Menin mediates epigenetic regulation via histone H3 lysine 9 methylation","volume":"4","author":"Cho","year":"2013","journal-title":"Cell Death Dis"},{"key":"15","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1158\/0008-5472.CAN-12-3158","article-title":"Menin epigenetically represses Hedgehog signaling in MEN1 tumor syndrome","volume":"73","author":"Hua","year":"2013","journal-title":"Cancer Res"},{"key":"16","first-page":"6135","article-title":"Menin a tumor suppressor represses JunD-mediated transcriptional activity by association with an mSin3A-histone deacetylase complex","volume":"63","author":"Youn","year":"2003","journal-title":"Cancer Res"},{"key":"17","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S1097-2765(04)00081-4","article-title":"Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus","volume":"13","author":"Meyerson","year":"2004","journal-title":"Mol Cell"},{"key":"18","doi-asserted-by":"publisher","first-page":"5639","DOI":"10.1128\/MCB.24.13.5639-5649.2004","article-title":"Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression","volume":"24","author":"Cleary","year":"2004","journal-title":"Mol Cell Biol"},{"key":"19","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1073\/pnas.0408836102","article-title":"Menin and MLL cooperatively regulate expression of cyclin- dependent kinase inhibitors","volume":"102","author":"Hess","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"20","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1158\/1541-7786.MCR-14-0457","article-title":"Dynamic epigenetic regulation by menin during pancreatic islet tumor formation","volume":"13","author":"Meyerson","year":"2015","journal-title":"Mol Cancer Res"},{"key":"21","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/00000478-200608000-00018","article-title":"Pancreatic endocrine tumors are a rare manifestation of the neurofibromatosis type 1 phenotype: molecular analysis of a malignant insulinoma in a NF-1 patient","volume":"30","author":"Komminoth","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"22","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1111\/jcmm.12237","article-title":"TSC2 epigenetic defect in primary LAM cells","volume":"18","author":"Gorio","year":"2014","journal-title":"Evidence of an anchorage-independent survival. J Cell Mol Med"},{"key":"23","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1016\/j.febslet.2014.02.026","article-title":"The multifaceted von Hippel-Lindau tumour suppressor protein","volume":"588","author":"Ohh","year":"2014","journal-title":"FEBS Lett"},{"key":"24","doi-asserted-by":"publisher","first-page":"365213","DOI":"10.1155\/2012\/365213","article-title":"RASSF1 Polymorphisms in Cancer","volume":"2012","author":"Baksh","year":"2012","journal-title":"Mol Biol Int"},{"key":"25","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1038\/sj.onc.1206582","article-title":"Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma","volume":"22","author":"Hoang-Vu","year":"2003","journal-title":"Oncogene"},{"key":"26","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/01.sla.0000086659.49569.9e","article-title":"Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms","volume":"238","author":"Yeo","year":"2003","journal-title":"Ann Surg"},{"key":"27","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/path.1784","article-title":"RASSF1A promoter methylation and 3p21 3 loss of heterozygosity are features of foregut but not midgut and hindgut malignant endocrine tumours","volume":"206","author":"Bordi","year":"2005","journal-title":"J Pathol"},{"key":"28","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/modpathol.3800490","article-title":"Epigenetic alterations in neuroendocrine tumors: methylation of RAS-association domain family 1 isoform A and p16 genes are associated with metastasis","volume":"18","author":"Rashid","year":"2005","journal-title":"Mod Pathol"},{"key":"29","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1002\/ijc.22569","article-title":"Analysis of molecular pathways in sporadic neuroendocrine tumors of the gastro-entero-pancreatic system","volume":"120","author":"Blum","year":"2007","journal-title":"Int J Cancer"},{"key":"30","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/1471-2407-11-351","article-title":"Methylation- associated down-regulation of RASSF1A and up-regulation of RASSF1C in pancreatic endocrine tumors","volume":"11","author":"Scarpa","year":"2011","journal-title":"BMC Cancer"},{"key":"31","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1210\/jcem.85.11.6970","article-title":"Alterations in the p16INK4a\/CDKN2A tumor suppressor gene in gastrinomas","volume":"85","author":"Jensen","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"32","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/modpathol.2012.53","article-title":"Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors","volume":"25","author":"Offerhaus","year":"2012","journal-title":"Mod Pathol"},{"key":"33","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000007810","article-title":"Low frequency of p16(INK4a) alterations in insulinomas","volume":"62","author":"Rothmund","year":"2000","journal-title":"Digestion"},{"key":"34","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1159\/000107270","article-title":"Identification of methylation- associated gene expression in neuroendocrine pancreatic tumor cells","volume":"7","author":"Simon","year":"2007","journal-title":"Pancreatology"},{"key":"35","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1210\/jc.2002-021027","article-title":"Frequent methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene in pancreatic endocrine tumors","volume":"88","author":"Bartsch","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"36","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1158\/1078-0432.CCR-08-1476","article-title":"O6-methylguanine DNA methyltransferase deficiency and response to temozolomide- based therapy in patients with neuroendocrine tumors","volume":"15","author":"Redston","year":"2009","journal-title":"Clin Cancer Res"},{"key":"37","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1158\/1078-0432.CCR-06-2053","article-title":"Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors","volume":"13","author":"Skogseid","year":"2007","journal-title":"Clin Cancer Res"},{"key":"38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000365514","article-title":"Prognostic and predictive roles of MGMT protein expression and promoter methylation in sporadic pancreatic neuroendocrine neoplasms","volume":"100","author":"Perren","year":"2014","journal-title":"Neuroendocrinology"},{"key":"39","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/bjc.2014.660","article-title":"O6-Methylguanine-DNA methyltransferase status in neuroendocrine tumours: prognostic relevance and association with response to alkylating agents","volume":"112","author":"Scoazec","year":"2015","journal-title":"Br J Cancer"},{"key":"40","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.1210\/jc.2009-0173","article-title":"Clinical implications of microsatellite instability and MLH1 gene inactivation in sporadic insulinomas","volume":"94","author":"Chen","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"41","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1677\/ERC-08-0331","article-title":"Hypermethylation of the IGF2 differentially methylated region 2 is a specific event in insulinomas leading to loss-of-imprinting and overexpression","volume":"16","author":"Tost","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"42","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.2217\/epi.15.85","article-title":"DNA methylation profiles distinguish different subtypes of gastroenteropancreatic neuroendocrine tumors","volume":"7","author":"Tost","year":"2015","journal-title":"Epigenomics"},{"key":"43","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1038\/ncomms3810","article-title":"Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY1","volume":"4","author":"Ning","year":"2013","journal-title":"Nat Commun"},{"key":"44","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1093\/carcin\/bgt018","article-title":"Deregulation of Wnt\/\u03b2-catenin signaling through genetic or epigenetic alterations in human neuroendocrine tumors","volume":"34","author":"Evers","year":"2013","journal-title":"Carcinogenesis"},{"key":"45","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000365449","article-title":"Prognostic relevance of aberrant DNA methylation in g1 and g2 pancreatic neuroendocrine tumors","volume":"100","author":"Furlan","year":"2014","journal-title":"Neuroendocrinology"},{"key":"46","doi-asserted-by":"publisher","first-page":"L13","DOI":"10.1530\/ERC-15-0108","article-title":"Epigenetic dysregulation and poorer prognosis in DAXX-deficient pancreatic neuroendocrine tumours","volume":"22","author":"Morris","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"47","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1126\/science.1207313","article-title":"Altered telomeres in tumors with ATRX and DAXX mutations","volume":"333","author":"Rasheed","year":"2011","journal-title":"Science"},{"key":"48","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1053\/j.gastro.2013","article-title":"Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors","volume":"146","author":"Perren","year":"2014","journal-title":"Gastroenterology"},{"key":"49","doi-asserted-by":"publisher","first-page":"4677","DOI":"10.1200\/JCO.2005.05.5194","article-title":"MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior","volume":"24","author":"Croce","year":"2006","journal-title":"J Clin Oncol"},{"key":"50","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1210\/en.2014-1966","article-title":"miR-144\/451 Promote Cell Proliferation via Targeting PTEN\/AKT Pathway in Insulinomas","volume":"156","author":"Cao","year":"2015","journal-title":"Endocrinology"},{"key":"51","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1210\/me.2014-1304","article-title":"Epigenetic regulation of the lncRNA MEG3 and its target c-MET in pancreatic neuroendocrine tumors","volume":"29","author":"Agarwal","year":"2015","journal-title":"Mol Endocrinol"},{"key":"52","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s12020-006-0008-1","article-title":"Association of DNA methylation and epigenetic inactivation of RASSF1A and beta-catenin with metastasis in small bowel carcinoid tumors","volume":"30","author":"Lloyd","year":"2006","journal-title":"Endocrine"},{"key":"53","doi-asserted-by":"publisher","first-page":"987","DOI":"10.4161\/epi.28936","article-title":"Global hypomethylation and promoter methylation in small intestinal neuroendocrine tumors: an in vivo and in vitro study","volume":"9","author":"Larsson","year":"2014","journal-title":"Epigenetics"},{"key":"54","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/890","article-title":"Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases","volume":"19","author":"Li","year":"1998","journal-title":"Nat Genet"},{"key":"55","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.humpath.2010.01.011","article-title":"DNA methyltransferases 1 3a and 3b overexpression and clinical significance in gastroenteropancreatic neuroendocrine tumors","volume":"41","author":"Sano","year":"2010","journal-title":"Hum Pathol"},{"key":"56","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1530\/ERC-13-0419","article-title":"TCEB3C a putative tumor suppressor gene of small intestinal neuroendocrine tumors","volume":"21","author":"Westin","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"57","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/sj.onc.1206123","article-title":"CpG island methylation in carcinoid and pancreatic endocrine tumors","volume":"22","author":"Rashid","year":"2003","journal-title":"Oncogene"},{"key":"58","doi-asserted-by":"publisher","first-page":"164","DOI":"10.5808\/GI.2013.11.4.164","article-title":"Interplay between Epigenetics and Genetics in Cancer","volume":"11","author":"Lee","year":"2013","journal-title":"Genomics Inform"},{"key":"59","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/modpathol.3800825","article-title":"Hypomethylation of LINE-1 and Alu in well-differentiated neuroendocrine tumors (pancreatic endocrine tumors and carcinoid tumors)","volume":"20","author":"Rashid","year":"2007","journal-title":"Mod Pathol"},{"key":"60","first-page":"3699","article-title":"Site- and grade-specific diversity of LINE1 methylation pattern in gastroenteropancreatic neuroendocrine tumours","volume":"32","author":"Mirmohammadsadegh","year":"2012","journal-title":"Anticancer Res"},{"key":"61","doi-asserted-by":"publisher","first-page":"L5","DOI":"10.1530\/ERC-13-0481","article-title":"Global DNA methylation patterns through an array-based approach in small intestinal neuroendocrine tumors","volume":"21","author":"Bj\u00f6rklund","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"62","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1186\/1471-2407-8-388","article-title":"Histone H1x is highly expressed in human neuroendocrine cells and tumours","volume":"8","author":"Happel","year":"2008","journal-title":"BMC Cancer"},{"key":"63","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.humpath.2009.08.007","article-title":"H3K4 dimethylation in hepatocellular carcinoma is rare compared with other hepatobiliary and gastrointestinal carcinomas and correlates with expression of the methylase Ash2 and the demethylase LSD1","volume":"41","author":"G\u00fctgemann","year":"2010","journal-title":"Hum Pathol"},{"key":"64","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/modpathol.2009.161","article-title":"MicroRNA expression in ileal carcinoid umors: downregulation of microRNA-133a with tumor progression","volume":"23","author":"Lloyd","year":"2010","journal-title":"Mod Pathol"},{"key":"65","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/modpathol.2012.216","article-title":"Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors","volume":"26","author":"Giandomenico","year":"2013","journal-title":"Mod Pathol"},{"key":"66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/genes6010001","article-title":"Down-Regulation of miR-129-5p and the let-7 Family in Neuroendocrine Tumors and Metastases Leads to Up-Regulation of Their Targets Egr1 G3bp1 Hmga2 and Bach1","volume":"6","author":"Friis-Hansen","year":"2014","journal-title":"Genes (Basel)"},{"key":"67","first-page":"4269","article-title":"Dual role of RASSF1 as a tumor suppressor and an oncogene in neuroendocrine tumors of the lung","volume":"30","author":"Viale","year":"2010","journal-title":"Anticancer Res"},{"key":"68","doi-asserted-by":"publisher","first-page":"6587","DOI":"10.1038\/sj.onc.1204798","article-title":"Expression of p15 and p15 5 products in neuroendocrine lung tumours: relationship with p15(INK4b) methylation status","volume":"20","author":"Gazzeri","year":"2001","journal-title":"Oncogene"},{"key":"69","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/1746-1596-8-201","article-title":"Cellular localization of protein arginine methyltransferase-5 correlates with grade of lung tumors","volume":"8","author":"Otterson","year":"2013","journal-title":"Diagn Pathol"},{"key":"70","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.humpath.2010.09.019","article-title":"High-grade neuroendocrine carcinomas of the lung highly express enhancer of zeste homolog 2 but carcinoids do not","volume":"42","author":"Xu","year":"2011","journal-title":"Hum Pathol"},{"key":"71","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/PAI.0b013e3182108e2e","article-title":"Epigenetic modifications of histone h4 in lung neuroendocrine tumors","volume":"19","author":"Fishbein","year":"2011","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"72","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/2045-3701-4-35","article-title":"Clinical biomarkers of pulmonary carcinoid tumors in never smokers via profiling miRNA and target mRNA","volume":"4","author":"Yang","year":"2014","journal-title":"Cell Biosci"},{"key":"73","doi-asserted-by":"publisher","first-page":"646","DOI":"10.7150\/jca.9955","article-title":"Gene Expression Analysis of the 26S Proteasome Subunit PSMB4 Reveals Significant Upregulation, Different Expression and Association with Proliferation in Human Pulmonary Neuroendocrine Tumours","volume":"5","author":"Zarogoulidis","year":"2014","journal-title":"J Cancer"},{"key":"74","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1159\/000381454","article-title":"Identification of MicroRNAs Differentially Expressed in Lung Carcinoid Subtypes and Progression","volume":"101","author":"Volante","year":"2015","journal-title":"Neuroendocrinology"},{"key":"75","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/j.1440-1827.2012.02845.x","article-title":"Altered expression of microRNA miR-21 miR-155 and let-7a and their roles in pulmonary neuroendocrine tumors","volume":"62","author":"Seo","year":"2012","journal-title":"Pathol Int"},{"key":"76","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1056\/NEJMp1500523","article-title":"A new initiative on precision medicine","volume":"372","author":"Varmus","year":"2015","journal-title":"N Engl J Med"},{"key":"77","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1056\/NEJMoa1316158","article-title":"CLARINET Investigators Lanreotide in metastatic enteropancreatic neuroendocrine tumors","volume":"371","author":"Martinez","year":"2014","journal-title":"N Engl J Med"},{"key":"78","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/S0140-6736(15)00817-X","article-title":"RAD001 in Advanced Neuroendocrine Tumours Fourth Trial (RADIANT-4) Study Group Everolimus for the treatment of advanced non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised placebo-controlled phase 3 study","volume":"387","author":"Sachs","year":"2016","journal-title":"Lancet"},{"key":"79","doi-asserted-by":"publisher","first-page":"6127","DOI":"10.1158\/1078-0432.CCR-14-1087","article-title":"Genome-wide DNA methylation analysis of lung carcinoma reveals one neuroendocrine and four adenocarcinoma epitypes associated with patient outcome","volume":"20","author":"Staaf","year":"2014","journal-title":"Clin Cancer Res"},{"key":"80","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1038\/modpathol.2014.74","article-title":"Different micro-RNA expression profiles distinguish subtypes of neuroendocrine tumors of the lung: results of a profiling study","volume":"27","author":"Wohlschlaeger","year":"2014","journal-title":"Mod Pathol"},{"key":"81","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1158\/2159-8290.CD-15-0068","article-title":"A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical Metastatic Developmental and Metabolic Characteristics","volume":"5","author":"Bl\u00e4ker","year":"2015","journal-title":"Cancer Discov"},{"key":"82","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000438902","article-title":"Reviewing the Osteotropism in Neuroendocrine Tumors: The Role of Epithelial-Mesenchymal Transition","volume":"103","author":"Silvestris","year":"2015","journal-title":"Neuroendocrinology"},{"key":"83","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/onc.2015.139","article-title":"CXCL12\/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks","volume":"35","author":"Zhang","year":"2016","journal-title":"Oncogene"},{"key":"84","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1530\/ERC-15-0092","article-title":"Blood and tissue neuroendocrine tumor gene cluster analysis correlate define hallmarks and predict disease status","volume":"22","author":"Modlin","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"85","doi-asserted-by":"publisher","first-page":"e2224","DOI":"10.1097\/MD.0000000000002224","article-title":"High Expression of MicroRNA-196a Indicates Poor Prognosis in Resected Pancreatic Neuroendocrine Tumor","volume":"94","author":"Hwang","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"86","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.1016\/j.bbagen.2014.09.017","article-title":"Epigenetics of cancer stem cells: Pathways and therapeutics","volume":"1840","author":"Meeran","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"87","first-page":"95","article-title":"Azacytidine induces cell cycle arrest and suppression of neuroendocrine markers in carcinoids","volume":"3","author":"Chen","year":"2010","journal-title":"Int J Clin Exp Med"},{"key":"88","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1677\/erc.1.01249","article-title":"Antiproliferative and proapoptotic effects of histone deacetylase inhibitors on gastrointestinal neuroendocrine tumor cells","volume":"13","author":"Scher\u00fcbl","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"89","doi-asserted-by":"publisher","DOI":"10.1159\/000441849","article-title":"Cytotoxic Effects of Valproic Acid on Neuroendocrine Tumour Cells","author":"Nilsson","year":"2015","journal-title":"Neuroendocrinology"},{"key":"90","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1634\/theoncologist.12-8-942","article-title":"Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells","volume":"12","author":"Chen","year":"2007","journal-title":"Oncologist"},{"key":"91","doi-asserted-by":"publisher","first-page":"39819","DOI":"10.1074\/jbc.M603578200","article-title":"Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cells","volume":"281","author":"Chen","year":"2006","journal-title":"J Biol Chem"},{"key":"92","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3109\/1061186X.2015.1066794","article-title":"Valproic acid induces NET cell growth arrest and enhances tumor suppression of the receptor-targeted peptide-drug conjugate via activating somatostatin receptor type II","volume":"24","author":"Yu","year":"2016","journal-title":"J Drug Target"},{"key":"93","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1245\/s10434-008-0194-6","article-title":"Combination therapy with histone deacetylase inhibitors and lithium chloride: a novel treatment for carcinoid tumors","volume":"16","author":"Chen","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"94","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1210\/jcem-67-5-1060","article-title":"The effects of sodium valproate on plasma somatostatin and insulin in humans","volume":"67","author":"Utsunomiya","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"95","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1634\/theoncologist.2011-0031","article-title":"A pilot phase II study of valproic acid for treatment of low-grade neuroendocrine carcinoma","volume":"16","author":"Loconte","year":"2011","journal-title":"Oncologist"},{"key":"96","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1158\/1078-0432.CCR-05-2689","article-title":"Cardiotoxicity of histone deacetylase inhibitor depsipeptide in patients with metastatic neuroendocrine tumors","volume":"12","author":"Grever","year":"2006","journal-title":"Clin Cancer Res"},{"key":"97","article-title":"A phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in low-grade neuroendocrine tumors","volume":"30","author":"LoConte","year":"2012","journal-title":"J Clin Oncol"},{"key":"98","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1634\/theoncologist.2012-0434","article-title":"Targeted therapies in neuroendocrine tumors (NET): clinical trial challenges and lessons learned","volume":"18","author":"Kulke","year":"2013","journal-title":"Oncologist"},{"key":"99","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1159\/000441775","article-title":"Flushing Out Carcinoid Syndrome: Beneficial Effect of the Anticancer Epigenetic Agent RRx-001 in a Patient with a Treatment-Refractory Neuroendocrine Tumor","volume":"8","author":"Roswarski","year":"2015","journal-title":"Case Rep Oncol"},{"key":"100","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.cancergen.2015.04.002","article-title":"Exome-level comparison of primary well-differentiated neuroendocrine tumors and their cell lines","volume":"208","author":"Banck","year":"2015","journal-title":"Cancer Genet"},{"key":"101","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1530\/JME-14-0304","article-title":"Whole-exome characterization of pancreatic neuroendocrine tumor cell lines BON-1 and QGP-1","volume":"54","author":"Op de Beeck","year":"2015","journal-title":"J Mol Endocrinol"},{"key":"102","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nmeth.3728","article-title":"Parallel single-cell sequencing links transcriptional and epigenetic heterogeneity","volume":"13","author":"Reik","year":"2016","journal-title":"Nat Methods"},{"key":"103","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.cell.2015.07.011","article-title":"Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses","volume":"162","author":"Slamon","year":"2015","journal-title":"Cell"},{"key":"104","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.cell.2015.07.056","article-title":"DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts","volume":"162","author":"De Carvalho","year":"2015","journal-title":"Cell"},{"key":"105","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/nm0116-8","article-title":"Take two: Combining immunotherapy with epigenetic drugs to tackle cancer","volume":"22","author":"Weintraub","year":"2016","journal-title":"Nat Med"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.10598","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T23:05:11Z","timestamp":1600902311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.10598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,13]]},"references-count":105,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2016,8,30]]}},"alternative-id":["10598","27418145"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.10598","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,13]]}}}